Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Real-life Study of Tumor Mutational Burden Assessment in First-line Lung Cancer

NCT04289259 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04289259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04289259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Real-life Study of Tumor Mutational Burden Assessment in First-line Lung Cancer
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Terminated
Start date
June 10, 2020
Completion date
July 6, 2020
Enrollment
6 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, non small cell lung cancer stage iii, non-small cell carcinoma of lung, non-small cell lung cancer stage iv